Leflunomide Inhibits rat-to-Mouse Cardiac Xenograft Rejection by Suppressing Adaptive Immune Cell Response and NF-κB Signaling Activation
Xenotransplantation is a potential solution for the severe shortage of human donor organs and tissues. The generation of humanized animal models attenuates strong innate immune responses, such as complement-mediated hyperacute rejection. However, acute vascular rejection and cell mediated rejection...
Guardado en:
Autores principales: | Yunhan Ma, Baiyi Xie, Junjun Guo, Yingyu Chen, Mengya Zhong, Qingru Lin, Jianyu Hua, Jiaying Zhong, Xuewei Luo, Guoliang Yan, Helong Dai, Zhongquan Qi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b8064bd5a1c498f85293c37590d46d2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
por: Cheng-bo Fang, et al.
Publicado: (2013) -
Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Peter BB Jones, et al.
Publicado: (2010) -
NF-κB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model
por: Jennifer M. Peterson, et al.
Publicado: (2018) -
Monitoring the Levels of Cellular NF-κB Activation States
por: Johanna Meier-Soelch, et al.
Publicado: (2021) -
Origin of the Functional Distinctiveness of NF-κB/p52
por: Gourisankar Ghosh, et al.
Publicado: (2021)